Catalyst

Slingshot members are tracking this event:

First Patient Enrolled in Mallinckrodt (MNK) Phase 4 Trial of H.P. Acthar Gel for Rheumatoid Arthritis

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
MNK

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 14, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Acthar Gel, Rheumatoid Arthritis